Novel Drug to Slow Cataracts on Their Path to Causing Blindness

The innovators behind commercializing a world-first drug to slow cataract growth and to delay cataracts forming, have been named as one of five finalists in The University of Queensland (UQ) Business School's $100,000 Enterprize business plan competition. The drug being commercially developed by Adelaide-based Calpain Therapeutics targets a protein in the eye's tissue.

Full Story →